Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012, Article ID 198206, 8 pages
http://dx.doi.org/10.1155/2012/198206
Research Article

Phenotyping of P105-Negative B Cell Subsets in Patients with Systemic Lupus Erythematosus

1Division of Rheumatology, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan
2Division of Clinical Nursing, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan

Received 25 May 2011; Accepted 25 July 2011

Academic Editor: Anisur Rahman

Copyright © 2012 Syuichi Koarada et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. H. Hahn, “Antibodies to DNA,” New England Journal of Medicine, vol. 338, pp. 1359–1368, 1998. View at Google Scholar
  2. C. A. von Muhlen and E. M. Tan, “Autoantibodies in the diagnosis of systemic rheumatic diseases,” Seminars in Arthritis and Rheumatism, vol. 24, no. 5, pp. 323–358, 1995. View at Google Scholar · View at Scopus
  3. P. E. Lipsky, “Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity,” Nature Immunology, vol. 2, no. 9, pp. 764–766, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. D. S. Pisetsky, “Anti-DNA and autoantibodies,” Current Opinion in Rheumatology, vol. 12, no. 5, pp. 364–368, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. N. A. Mitchison and L. R. Wedderburn, “B cells in autoimmunity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 16, pp. 8750–8751, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Miyake, Y. Yamashita, Y. Hitoshi, K. Takatsu, and M. Kimoto, “Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells,” Journal of Experimental Medicine, vol. 180, no. 4, pp. 1217–1224, 1994. View at Google Scholar · View at Scopus
  7. Y. Nagai, R. Shimazu, H. Ogata et al., “Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide,” Blood, vol. 99, no. 5, pp. 1699–1705, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Ogata, I. Su, K. Miyake et al., “The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells,” Journal of Experimental Medicine, vol. 192, no. 1, pp. 23–29, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Blumenthal, T. Kobayashi, L. M. Pierini et al., “RP105 Facilitates Macrophage Activation by Mycobacterium tuberculosis Lipoproteins,” Cell Host and Microbe, vol. 22, pp. 35–46, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Tada, S. Koarada, F. Morito et al., “Toll-like receptor homolog RP105 modulates the antigen-presenting cell function and regulates the development of collagen-induced arthritis,” Arthritis Research and Therapy, vol. 10, no. 5, article R121, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Divanovic, A. Trompette, S. F. Atabani et al., “Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105,” Nature Immunology, vol. 6, no. 6, pp. 571–578, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Koarada, Y. Tada, O. Ushiyama et al., “B cells lacking RP105, a novel B cell antigen, in systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 42, no. 12, pp. 2593–2600, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Koarada, M. Ide, Y. Haruta et al., “Two cases of antinuclear antibody negative lupus showing increased proportion of B cells lacking RP105,” Journal of Rheumatology, vol. 32, no. 3, pp. 562–564, 2005. View at Google Scholar · View at Scopus
  14. Y. Kikuchi, S. Koarada, Y. Tada et al., “RP105-lacking B cells from lupus patients are responsible for the production of immunoglobulins and autoantibodies,” Arthritis and Rheumatism, vol. 46, no. 12, pp. 3259–3265, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. D. A. Culton, B. P. O'Conner, K. L. Conway et al., “Early preplasma cells define a tolerance checkpoint for autoreactive B cells,” Journal of Immunology, vol. 176, no. 2, pp. 790–802, 2006. View at Google Scholar · View at Scopus
  16. E. M. Tan, A. S. Cohen, and J. F. Fries, “The 1982 revised criteria for the classification of systemic lupus erythrematosus,” Arthritis and Rheumatism, vol. 25, no. 11, pp. 1271–1277, 1982. View at Google Scholar · View at Scopus
  17. M. C. Hochberg, “Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 40, no. 9, p. 1725, 1997. View at Google Scholar · View at Scopus
  18. K. Agematsu, S. Hokibara, H. Nagumo, and A. Komiyama, “CD27: a memory B-cell marker,” Immunology Today, vol. 21, no. 5, pp. 204–206, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. A. M. Jacobi, M. Odendahl, K. Reiter et al., “Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 48, no. 5, pp. 1332–1342, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Dörner and P. E. Lipsky, “Correlation of circulating CD27high plasma cells and disease activity in systemic lupus erythematosus,” Lupus, vol. 13, no. 5, pp. 283–289, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Jung, J. Choe, L. Li et al., “Regulation of CD27 expression in the course of germinal center B cell differentiation: the pivotal role of IL-10,” European Journal of Immunology, vol. 30, no. 8, pp. 2437–2443, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Jourdan, A. Caraux, J. de Vos et al., “An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization,” Blood, vol. 114, no. 25, pp. 5173–5181, 2009. View at Publisher · View at Google Scholar · View at Scopus